Fig. 1
From: Clinical significance and potential molecular mechanisms of SYT15 expression in lung adenocarcinoma
SYT15 expression difference between LUAD and normal tissues and its association with clinical stages. (A–B) SYT15 mRNA levels in LUAD as analyzed by the TCGA and GEO databases. (C) SYT15 mRNA expression in 40 clinical LUAD samples. (D) SYT15 protein expression in LUAD according to the CPTAC database. (E) SYT15 mRNA expression in different patient subgroups of the TCGA population. (F) SYT15 mRNA expression across different patient subgroups in the GEO cohort. n.s. p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
